- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.25 | 1.94 |
NAV | ₹268.01 | ₹419.28 |
Fund Started | 01 Aug 2005 | 04 Jun 1999 |
Fund Size | ₹1037.49 Cr | ₹3610.51 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.25
1.94
NAV
₹268.01
₹419.28
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1037.49 Cr
₹3610.51 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 20.02% | 21.90% |
3 Year | 21.84% | 26.34% |
5 Year | 22.12% | 24.95% |
1 Year
20.02%
21.90%
3 Year
21.84%
26.34%
5 Year
22.12%
24.95%
Holding Analysis
Equity | 99.21% | 96.93% |
Cash | 0.78% | 2.99% |
Equity
99.21%
96.93%
Cash
0.78%
2.99%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.65% |
Cipla Ltd. | 5.81% |
Ajanta Pharma Ltd. | 4.40% |
Dr. Reddy's Laboratories Ltd. | 4.35% |
Glenmark Pharmaceuticals Ltd. | 4.07% |
Procter & Gamble Health Ltd. | 3.65% |
Apollo Hospitals Enterprise Ltd. | 3.57% |
Fortis Healthcare Ltd. | 3.12% |
Divi's Laboratories Ltd. | 3.10% |
Alkem Laboratories Ltd. | 2.99% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.45% |
Max Healthcare Institute Ltd. | 6.68% |
Divi's Laboratories Ltd. | 6.00% |
Cipla Ltd. | 4.79% |
Lupin Ltd. | 4.72% |
Lonza Group Ag | 4.38% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.72% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Ami Organics Ltd. | 3.38% |
Fund Manager
Name | Kamal Gada | Tanmaya Desai |
Start Date | 02 May 2022 | 27 Jun 2011 |
Name
Kamal Gada
Tanmaya Desai
Start Date
02 May 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 01 Aug 2005 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999